Template:Percutaneous Coronary Intervention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 38: | Line 38: | ||
! | ! | ||
:[[Percutaneous Coronary Intervention (PCI) | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous Coronary Intervention (PCI) left main coronary artery disease|Left Main Coronary Artery Disease]] | |||
|- | |||
! | |||
:[[Percutaneous Coronary Intervention (PCI) | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous Coronary Intervention (PCI) non-left main coronary artery disease|Non-Left Main Coronary Artery Disease]] | |||
|- | |||
! | |||
:[[Percutaneous Coronary Intervention (PCI) | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous Coronary Intervention (PCI) revascularization to improve symptoms|Revascularization to Improve Symptoms]] | |||
|- | |||
! | |||
:[[Percutaneous Coronary Intervention (PCI) | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous Coronary Intervention (PCI) dual antiplatelet therapy compliance and stent thrombosis|Dual Antiplatelet Therapy Compliance and Stent Thrombosis]] | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
:[[Percutaneous Coronary Intervention (PCI) | ::[[Percutaneous Coronary Intervention (PCI) hybrid coronary revascularization|Hybrid Coronary Revascularization]] | ||
|- | |- | ||
! | ! | ||
Line 55: | Line 71: | ||
! | ! | ||
Pre-procedural Considerations: | Pre-procedural Considerations: | ||
|- | |||
! | |||
:[[Percutaneous Coronary Intervention (PCI) | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous Coronary Intervention (PCI) radiation safety|Radiation Safety]] | |||
|- | |||
! | |||
:[[Percutaneous Coronary Intervention (PCI) | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous Coronary Intervention (PCI) contrast-induced acute kidney injury|Contrast-Induced Acute Kidney Injury]] | |||
|- | |||
! | |||
:[[Percutaneous Coronary Intervention (PCI) | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous Coronary Intervention (PCI) anaphylactoid reactions|Anaphylactoid Reactions]] | |||
|- | |||
! | |||
:[[Percutaneous Coronary Intervention (PCI) | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous Coronary Intervention (PCI) statin treatment|Statin Treatment]] | |||
|- | |||
! | |||
:[[Percutaneous Coronary Intervention (PCI) | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous Coronary Intervention (PCI) bleeding risk|Bleeding Risk]] | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
::[[Percutaneous Coronary Intervention (PCI) role of onsite surgical backup|Role of Onsite Surgical Backup]] | |||
::[[Percutaneous Coronary Intervention (PCI) | |||
|- | |- | ||
! | ! |
Revision as of 20:49, 5 October 2012
Percutaneous Coronary Intervention Microchapters |
Guideline Recommendations |
---|
CAD Revascularization: |
Pre-procedural Considerations: |
Procedural Considerations:
|
Post-Procedural Considerations: |
Quality and Performance Considerations: |
Percutaneous Coronary Intervention On the Web |
American Roentgen Ray Society Images of Percutaneous Coronary Intervention |
Directions to Hospitals Treating Percutaneous Coronary Intervention |
Risk calculators and risk factors for Percutaneous Coronary Intervention |